Towards in vivo neurochemical profiling of multiple sclerosis with MR spectroscopy at 7 Tesla: Cross-sectional assessment of frontal-cortex glutathione, GABA, and glutamate in individuals with relapsing-remitting and progressive multiple sclerosis
Multiple sclerosis (MS) is an autoimmune disease that damages the central nervous system and affects an estimated 2.3 million people worldwide. One potential key to understanding MS is investigating the metabolic distinctions between its relapsing-remitting (RR-MS) and progressive courses (P-MS). We obtained single-voxel metabolic 1H spectra at 7 Tesla from the frontal cortex of RR-MS and P-MS pat
